Telehealth companies are aggressively marketing GLP-1s as cosmetic elixirs for anyone who wants to lose a few pounds.

A new study reported that Novo Nordisk spent $7.5 million over 2 years on more than 15,000 internet keywords — many focused on weight loss — that drove 2.4 million paid visits to its Ozempic.com ...

Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include ...

In the cash grab for patients eager to get on GLP-1 weight loss drugs like Ozempic, startups are getting so sloppy that their marketing materials look like unintentional parody. Consider MEDVi, an ...

Casting for a weight loss treatment and ozempic social media UGC ad for Felix Health, a healthcare company that provides online treatment and medication. Problem-solution explainer video in first ...

Editor's Note: The original version of this article omitted that NextMed neither admitted or denied the allegations made in the Federal Trade Commission’s complaint or order, but agreed to the terms ...

In eight months, a startup called NextMed has emerged as a growing service among many trying to capitalize on the craze for drugs such as Ozempic, Wegovy and Mounjaro that are often prescribed for ...

An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression of Alzheimer’s disease in closely watched trials, drugmaker Novo Nordisk ...

Anecdotal reports and a case series suggest that Ozempic and other GLP-1 receptor agonists may in some cases lead to underproduction of saliva and a dry mouth. (Photo: Getty) People have been mouthing ...